To rapidly identify carbapenemase producers in En-terobacteriaceae, we developed the Carba NP test. The test uses isolated bacterial colonies and is based on in vitro hy-drolysis of a carbapenem, imipenem. It was 100 % sensitive and specifi c compared with molecular-based techniques. This rapid (<2 hours), inexpensive technique may be imple-mented in any laboratory. Multidrug resistance is emerging worldwide at an alarming rate among a variety of bacterial species, causing both community-acquired and nosocomial infec-tions (1). Carbapenems, the last line of therapy, are now fre-quently needed to treat nosocomial infections, and increas-ing resistance to this class of β-lactams leaves the health care system with almost no effective drugs ...
Early identification of infections caused by carbapenemase-producing Enterobacterales (CPE) can help...
The rapid detection of blood stream infections (BSI) by carbapenemase-producing Enterobacterales (CP...
Carbapenem resistance are intrinsic in a few clinical bacteria, such as Stenotrophomonas maltophilia...
To rapidly identify carbapenemase producers in Enterobacteriaceae, we developed the Carba NP test. T...
To rapidly identify carbapenemase producers in Enterobacteriaceae, we developed the Carba NP test. T...
To rapidly identify carbapenemase producers in Enterobacteriaceae, we developed the Carba NP test. T...
Rapidly progressing antibiotic resistance is a great challenge in therapy. In particular, the infect...
Carbapenems are considered the last resort for the treatment of multidrug-resistant Enterobacteriace...
AbstractThe biochemical-based Carba NP test has been evaluated to detect carbapenemase-producing Ent...
Carbapenems are considered the last resort for the treatment of multidrug-resistant Enterobacteriace...
Rapid-screening methods to confirm the presence of resistance mechanisms in multidrug-resistant bact...
Performances of the Rapidec Carba NP test (bioMérieux) were evaluated for detection of all types of ...
patients in clinical settings. Non-fermenting Gram-negative bacilli (NFGNB) are common nosocomial pa...
This study evaluated the performance of the Rapidec Carba NP test, which was introduced recently int...
Aims: Carbapenems are usually the choice of antimicrobials in infections caused by Enterobacteriacea...
Early identification of infections caused by carbapenemase-producing Enterobacterales (CPE) can help...
The rapid detection of blood stream infections (BSI) by carbapenemase-producing Enterobacterales (CP...
Carbapenem resistance are intrinsic in a few clinical bacteria, such as Stenotrophomonas maltophilia...
To rapidly identify carbapenemase producers in Enterobacteriaceae, we developed the Carba NP test. T...
To rapidly identify carbapenemase producers in Enterobacteriaceae, we developed the Carba NP test. T...
To rapidly identify carbapenemase producers in Enterobacteriaceae, we developed the Carba NP test. T...
Rapidly progressing antibiotic resistance is a great challenge in therapy. In particular, the infect...
Carbapenems are considered the last resort for the treatment of multidrug-resistant Enterobacteriace...
AbstractThe biochemical-based Carba NP test has been evaluated to detect carbapenemase-producing Ent...
Carbapenems are considered the last resort for the treatment of multidrug-resistant Enterobacteriace...
Rapid-screening methods to confirm the presence of resistance mechanisms in multidrug-resistant bact...
Performances of the Rapidec Carba NP test (bioMérieux) were evaluated for detection of all types of ...
patients in clinical settings. Non-fermenting Gram-negative bacilli (NFGNB) are common nosocomial pa...
This study evaluated the performance of the Rapidec Carba NP test, which was introduced recently int...
Aims: Carbapenems are usually the choice of antimicrobials in infections caused by Enterobacteriacea...
Early identification of infections caused by carbapenemase-producing Enterobacterales (CPE) can help...
The rapid detection of blood stream infections (BSI) by carbapenemase-producing Enterobacterales (CP...
Carbapenem resistance are intrinsic in a few clinical bacteria, such as Stenotrophomonas maltophilia...